$2.19 Billion is the total value of Prescott General Partners LLC's 12 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 20.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
CACC | CREDIT ACCEP CORP MICH | $939,484,000 | -20.0% | 1,707,005 | 0.0% | 42.82% | +6.6% | |
W | WAYFAIR INCcl a | $423,538,000 | -41.7% | 3,823,239 | 0.0% | 19.31% | -22.3% | |
WRLD | WORLD ACCEP CORP DEL | $390,873,000 | -21.8% | 2,037,495 | 0.0% | 17.82% | +4.1% | |
CMPR | CIMPRESS PLC | $248,414,000 | -11.2% | 3,906,492 | 0.0% | 11.32% | +18.3% | |
YELP | Sell | YELP INCcl a | $99,252,000 | -28.2% | 2,909,751 | -23.7% | 4.52% | -4.3% |
GIC | Sell | GLOBAL INDUSTRIAL COMPANY | $41,244,000 | -21.4% | 1,279,677 | -0.2% | 1.88% | +4.7% |
VAPO | Buy | VAPOTHERM INC | $35,546,000 | -2.7% | 2,557,243 | +45.0% | 1.62% | +29.6% |
ME | Buy | 23ANDME HOLDING CO | $5,453,000 | -27.6% | 1,423,829 | +26.0% | 0.25% | -3.5% |
Buy | HUMACYTE INC | $4,413,000 | +660.9% | 625,100 | +681.4% | 0.20% | +905.0% | |
LCTX | LINEAGE CELL THERAPEUTICS IN | $2,852,000 | -37.1% | 1,851,851 | 0.0% | 0.13% | -16.1% | |
SANA | Buy | SANA BIOTECHNOLOGY INC | $2,609,000 | +733.5% | 315,800 | +1463.4% | 0.12% | +981.8% |
AGE | AGEX THEREPEUTICS INC | $158,000 | -21.8% | 185,185 | 0.0% | 0.01% | 0.0% | |
COUR | Exit | COURSERA INC | $0 | – | -17,000 | -100.0% | -0.01% | – |
SKIN | Exit | THE BEAUTY HEALTH COMPANY | $0 | – | -20,000 | -100.0% | -0.02% | – |
Exit | LUMIRADX LIMITED | $0 | – | -94,474 | -100.0% | -0.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CREDIT ACCEPTANCE CORP. | 42 | Q3 2023 | 60.1% |
WORLD ACCEPTANCE CORP. | 42 | Q3 2023 | 17.8% |
YELP INC. | 32 | Q3 2023 | 9.2% |
ALLIANCE DATA SYSTEMS CORP. | 32 | Q1 2021 | 5.8% |
SYSTEMAX INC. | 32 | Q1 2021 | 3.2% |
WAYFAIR INC. | 29 | Q3 2023 | 47.3% |
NU SKIN ENTERPRISES, INC. | 26 | Q4 2019 | 8.7% |
COPART, INC. | 23 | Q4 2018 | 4.9% |
CIMPRESS N.V. | 20 | Q3 2019 | 30.1% |
AGEX THEREPEUTICS INC | 20 | Q3 2023 | 0.0% |
View Prescott General Partners LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
VAPOTHERM INCSold out | December 01, 2022 | 0 | 0.0% |
CREDIT ACCEPTANCE CORP | May 09, 2022 | 1,657,373 | 12.6% |
GLOBAL INDUSTRIAL Co | February 14, 2022 | 1,282,421 | 3.4% |
SYSTEMAX INC | February 16, 2021 | 1,777,633 | 4.7% |
WORLD ACCEPTANCE CORP | February 12, 2020 | 2,037,495 | 25.7% |
CIMPRESS N.V. | November 15, 2019 | 3,906,492 | 14.0% |
NU SKIN ENTERPRISES INC | February 14, 2019 | 1,142,959 | 2.1% |
LIFELOCK, INC.Sold out | February 14, 2018 | 0 | 0.0% |
NEUSTAR INCSold out | February 14, 2018 | 0 | 0.0% |
Support.com, Inc. | February 14, 2014 | 3,756,364 | 7.1% |
View Prescott General Partners LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
SC 13G/A | 2023-02-14 |
SC 13G/A | 2023-02-14 |
SC 13G/A | 2022-12-01 |
View Prescott General Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.